Assessing Suitability of a Colorectal Cancer Screening Program in Oman

Colorectal cancer is among the most common cancers globally and carries a high mortality rate. The incidence of colorectal cancer has been increasing in the Middle East, including in Oman. While many countries have implemented a bowel cancer screening program, Oman has yet to establish one. A standa...

Full description

Saved in:
Bibliographic Details
Published inCurēus (Palo Alto, CA) Vol. 14; no. 7; p. e27011
Main Authors Bondre, Mohammed Fayyadh, Al Qubtan, Murtadha, Al Harthy, Salim O
Format Journal Article
LanguageEnglish
Published Palo Alto Cureus Inc 19.07.2022
Cureus
Subjects
Colonoscopy
Colorectal cancer
Coronaviruses
COVID-19
Expenditures
Feces
General Surgery
Genetic testing
Hemoglobin
Laboratories
Medical screening
Mortality
Observatories
Oncology
Patients
Population
Public Health
Sexes
United States > US
Qatar
Oman
Online AccessGet full text

Cover

More Information
Summary:Colorectal cancer is among the most common cancers globally and carries a high mortality rate. The incidence of colorectal cancer has been increasing in the Middle East, including in Oman. While many countries have implemented a bowel cancer screening program, Oman has yet to establish one. A standard tool for bowel cancer screening is a fecal immunochemical test where a fecal sample is sent to a laboratory to check for blood content in the feces. In Oman, such fecal test kits are available at the primary health care level, but primary care physicians were unaware of the signs and symptoms or screening methods for colorectal cancer. This review article aims to assess the suitability of a colorectal cancer screening program in Oman using guidelines from the Supporting the Use of Research Evidence (SURE) collaboration.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:2168-8184
2168-8184
DOI:10.7759/cureus.27011